22nd Century Group (XXII)
(Delayed Data from NSDQ)
$0.70 USD
-0.05 (-6.79%)
Updated Jun 10, 2024 04:00 PM ET
After-Market: $0.70 0.00 (-0.64%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
22nd Century Group, Inc [XXII]
Reports for Purchase
Showing records 61 - 80 ( 134 total )
Company: 22nd Century Group, Inc
Industry: Tobacco
FDA Announces Plan to Propose Maxim Nicotine Content in Cigarettes
Provider: Roth Capital Partners, Inc.
Analyst: WRIGHT B
Company: 22nd Century Group, Inc
Industry: Tobacco
Buy: Low-Nic Mandate Added to Unified Agenda of Regulatory and Deregulatory Actions.
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: MCILREE J
Company: 22nd Century Group, Inc
Industry: Tobacco
Company: 22nd Century Group, Inc
Industry: Tobacco
Company: 22nd Century Group, Inc
Industry: Tobacco
Buy: Nic Mandate Will be Major Driver of Value for XXII.
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: MCILREE J
Company: 22nd Century Group, Inc
Industry: Tobacco
Ag Tech Invitation: 8th Annual ROTH London Conference
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: 22nd Century Group, Inc
Industry: Tobacco
Company: 22nd Century Group, Inc
Industry: Tobacco
Company: 22nd Century Group, Inc
Industry: Tobacco
Buy: GVB Biopharma Acquisition. More than Doubles Revenue.
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: MCILREE J
Company: 22nd Century Group, Inc
Industry: Tobacco
Company: 22nd Century Group, Inc
Industry: Tobacco
Buy: Q1 Review. Early Circle K Results Positive.
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: MCILREE J
Company: 22nd Century Group, Inc
Industry: Tobacco
Strong 1Q, Execution on VLN? Pilot Launch, and Expansion Preparations
Provider: Roth Capital Partners, Inc.
Analyst: WRIGHT B
Company: 22nd Century Group, Inc
Industry: Tobacco
Buy: Q1 Report This Week. Menthol Ban, Circle K. Low-Nic Mandate.
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: MCILREE J
Company: 22nd Century Group, Inc
Industry: Tobacco
Company: 22nd Century Group, Inc
Industry: Tobacco
FDA Issues Plan to Ban Menthol Cigarettes with VLN? a Logical Off Ramp
Provider: Roth Capital Partners, Inc.
Analyst: WRIGHT B
Company: 22nd Century Group, Inc
Industry: Tobacco
Company: 22nd Century Group, Inc
Industry: Tobacco
We initiate coverage with a Buy rating and a $6 per-share price target
Provider: Roth Capital Partners, Inc.
Analyst: WRIGHT B
Company: 22nd Century Group, Inc
Industry: Tobacco
Company: 22nd Century Group, Inc
Industry: Tobacco
Buy: VLN Pilot at Circle K Scheduled to Begin this Month
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: MCILREE J
Company: 22nd Century Group, Inc
Industry: Tobacco
Buy: Hemp/Cannabis plant transformation demonstrated with KeyGene .
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: MCILREE J